
Leveraging machine learning and data to accelerate drug discovery and development.
Visit WebsitePros
Cons
Insitro offers paid plans. Visit their website for current pricing details.
No reviews yet. Be the first to review Insitro!
Top alternatives based on features, pricing, and user needs.

AI community and platform
Developing Smart Targeted Radioligands for precision oncology using an AI-driven discovery engine.
Translating scientific discoveries into medical solutions for patients.
Developing innovative therapies for chronic and debilitating diseases.
Developing novel small molecule therapeutics for life-threatening diseases.
Advancing bioinformatics solutions for life science research and drug discovery.
Ultra-sensitive cancer diagnostics for enhanced drug development and patient care.
Insitro is a drug discovery and development company that utilizes machine learning and large-scale data to identify therapeutic insights and accelerate the creation of new medicines. They integrate in vitro cellular data with human clinical data to build a platform for drug development.
Insitro is a drug discovery company, not a software product with a direct pricing model for external users. Its services and products are likely part of partnerships or internal development, and therefore, no public pricing information is available.
No, Insitro is a drug discovery company and does not offer free services or products to the general public. Its operations involve significant research and development investments.
Insitro is for patients who can benefit from new medicines, and for pharmaceutical partners interested in leveraging machine learning for drug discovery. Internally, it's for life scientists, data scientists, engineers, and drug hunters who collaborate on its platform.
Source: insitro.com